Arcus Biosciences, Inc.·4

Oct 5, 5:02 PM ET

Grossman William 4

4 · Arcus Biosciences, Inc. · Filed Oct 5, 2020

Insider Transaction Report

Form 4
Period: 2020-10-02
Grossman William
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-10-02$17.00/sh+100,000$1,700,000100,000 total
    Exercise: $17.00Exp: 2030-10-01Common Stock (100,000 underlying)
  • Award

    Common Stock

    2020-10-02+100,000100,600 total
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in quarterly installments after October 2, 2020, subject to the Reporting Person's continued service to the Company.
  • [F2]The option is exercisable in 48 equal monthly installments after October 2, 2020, subject to the Reporting Person's continued service to the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION